Wang, Fu-Hui
Hsieh, Chia-Ying
Shen, Ching-I.
Chuang, Chang-Han
Chung, Yu-Hsuan
Kuo, Chi-Chung
Lee, Kuan-Der
Lin, Chih-Lung
Su, Hong-Lin
Article History
Received: 3 May 2022
Accepted: 5 December 2022
First Online: 15 December 2022
Competing interests
: The authors have the following competing interests. The technology transfer office of National Chung Hsing University has received consultancy, speaker fees, and research grants on behalf of HLS from Duogenic StemCells Corp and Hualien Tzu-Chi Medical Center. FHW, CYH, and JIS are employees of Duogenic StemCells Corp. FHW, CYH, JIS, CHC, CCK, and CLL are shareholders of Duogenic StemCells Corp. There are patents, products in development, and marketed products associated with this research.